未登录PRKAR1B as an oncogenic biomarker for diagnostic and prognostic stratification of tumor immunity, proliferation, and migration in head and neck squamous cell carcinomaPRKAR1B作为头颈鳞状细胞癌中肿瘤免疫、增殖和迁移的诊断与预后分层的致癌生物标志物
Zhao, Peng; Li, Kang; Xiu, Wufeng; Liu, Zhaokun; Huang, Yanxiao; Jiang, Youfang; Zhang, Peng; Peng, Lixiang
分享
收藏Polygonatum sibiricum Delar. ex Redoute: A Potential Functional Food for the Prevention and Treatment of HyperuricemiaPolygonatum sibiricum Delar. ex Redoute:一种预防与治疗高尿酸血症的潜在功能食品
Zhao, Peng; Liu, Wenjing; He, Minyang; Cao, Weiyou; Xu, Qichang; Hao, Qing; Wang, Lijun; Liu, Ying; Wang, Jingyu; Wang, Feixue; Jiang, Lin; Li, Songze; Dai, Chunyan; Zheng, Qiusheng; Ma, Jun; Fan, Xiangcheng; Han, Jichun
分享
收藏
分享
收藏
分享
收藏A randomized, controlled, multicenter phase III study of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) as neoadjuvant treatment for resectable microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) colon cancer一项随机、对照、多中心III期研究,评估IBI310(anti-CTLA-4 antibody)联合sintilimab(anti-PD-1 antibody)作为可切除微卫星高度不稳定/错配修复缺陷(MSI-H/dMMR)结肠癌的新辅助治疗方案。
Xu, R-H.; Wang, F.; Chen, G.; Hu, Y.; Ding, P-R.; Qiu, M.; Zhao, P.; Sun, Y.; Jiang, W.; Song, Z.; Ma, J.; Liu, H.; Lu, X.; Guo, Q.; Zhou, H.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Global, regional, and national childhood cancer burden, 1990-2019: An analysis based on the Global Burden of Disease Study 20191990至2019全球、区域和国家儿童癌症负担: 基于全球疾病负担研究2019的分析
Wu, Ying; Deng, Yujiao; Wei, Bajin; Xiang, Dong; Hu, Jingjing; Zhao, Peng; Lin, Shuai; Zheng, Yi; Yao, Jia; Zhai, Zhen; Wang, Shuqian; Lou, Weiyang; Yang, Si; Zhang, Dai; Lyu, Jun; Dai, Zhijun
分享
收藏GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells
Yu, Tenghua; Cheng, Hong; Ding, Zhijuan; Wang, Zhiliang; Zhou, Lixia; Zhao, Peng; Tan, Shengxing; Xu, Xue; Huang, Xianming; Liu, Manran; Peng, Meixi; Qiu, Yu-an
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏